Current studies1~5) have provided considerable evidence of increase of /?-glucuronidase activity in human tumors and suggested that /?-glucuronidase plays a key role in degradation of basement membranes during metastasis of the tumor cells, and showed that pglucuronidase inhibitors inhibit tumor-cell metastasis. In the course of our studies6~16) of new drugs for tumor metastasis based on siastatin B (1),17) we showed that synthetic (35' ,45' , 5^,6^)-6-(trifluoroacetamido)-4,5-dihydroxypiperidine-3-carboxylic acid (2) and (3R,4R, 5JR,6i^)-6-(trifluoroacetamido)-3,4, 5-trihydroxypiperidine-3-carboxylic acid (3) have the marked inhibitory activity against /?-glucuronidase. 1 5) They were also found to show the inhibition of highly metastatic B16 variant (B16 BL6) and Lewis lung carcinoma (3LL) cell invasion through reconstituted basement membranes and the potent suppression of pulmonary metastasis of B16 BL6 and 3LL cells in mice.15'16) These results prompted us to further modify the amide function at C-6 of 1 focused on the glucuronidase inhibition and suppression of lung metastasis of tumor cell. Here, we wish to report the syntheses of (3£,4£,5i?,6i?)-6-(trichloroacetamido) and (3S,4S,5i?,6i?)-6-guanidino-4,5-dihydroxypiperidine-3-carboxylic acids (4 and 5) having inhibitory activity for -glucuronidase and pulmonary metastasis of B16 BL6.
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Chemistry
The potent inhibition of 2 and 3 for jS-glucurdnidase suggest that the trifluoroacetamide function may play an important role in the strong binding of l-7V-iminosugar to /J-glucuronidase.
In order to examine the neighboring participation of amide group of 1 in jS-glucuronidase inhibition, replacement of acetamide function by trichloroacetamide and guanidino ones are next undertaken. The starting (2S,3R,4S,5R)-2-amino-N-(tert-butoxycarbonyl)-5-hydroxymethyl-3,4-0-isopropyridene-3,4- vivo pretreatment with 4 and 5 as shown in Table 2 .
Compounds 4 and 5 had no significant effects on cell growth at the concentrations used in this study (data not shown). Tables 1 and 2 show that the inhibitory activity for B16 BL6 metastasis is proportional to the inhibitory activity against /?-glucuronidase. On the other hand, Nakajima et #/.3'23'24) proved that heparanase (endo-jS-glucuronidase) activity correlates with the lung colonization abilities of murine B16 melanomacells by extracellular matrix degradation. These facts suggest that 4 and 5 as glucuronidase inhibitors inhibit extracellular matrix degradation and/or modify cell-surface glycoconjugate of B16 BL6 cells, resulting in the inhibition observed of experimental pulmonary metastasis of B16
BL6. These facts indicate that the antimetastatic effect of 4 and 5 may be due to its antiinvasive rather than antiproliferative activities. The present study promise a way to inhibit tumor metastasis through a better understanding of biochemical processes. (25,3i?,4tS, 5^)-
To a soln of 6 (124mg) in dichloromethane (2.5ml) were added pyridine (0.13ml) and trichloroacetyl chloride (0.1 ml) at 0°C, and the mixture was stirred at the same temperature for 10 minutes. After dilution with chloroform, the soln was washed with satd aq NaHCO3 soln and H2O, dried over MgSO4, and filtered. Evaporation of the filtrate gave a pale yellow solid. The solid was dissolved in a satd methanolic K2CO3soln (3ml). After being stirred at room temperature for 10 minutes, evaporation of the solvent gave a solid. The solid was dissolved in chloroform, and the soln was washed with satd aq NH4C1soln, dried over MgSO4, and filtered. Evaporation of the solvent gave a solid, which was subjected to column chromatography on silica gel. Elution with a mixture oftoluene -acetone (5 : 1) gave 7 (162mg, 88%) as a colorless foam: [a]£5 +16.8°(c 3.8, MeOH); IR (CHC13) 3420, 2980, 2930, 2900, 1720, 1700, 1490, 1460, 1395, 1385, 1370, 1360, 1325, 1280(sh) (3 SAS,5R,6R)-N-(tert-Butoxycarbony\)-6-(tnch\oro-acetamido)-4,5-dihydroxy-4,5-6>-isopropylidenepiperidine-3-carboxylic Acid (8) To a soln of7 (152mg> in a mixture of CC14(2ml) and CH3CN(2ml) were added a soln ofNaIO4 (218 mg) in water (3ml) and RuO2 (8mg), and the mixture was vigorously stirred at room temperature for 30 minutes.
The phases were separated. (3 5' ,4tS' , 5^,6^)-4, 5-Dihydroxy-6-(trichloroacetamido)-piperidine-3-carboxylic Acid (4) Compound8 (32mg) was dissolved in 4m hydrogen chloride in dioxane (1 ml), and the mixture was stirred at room temperature overnight. The resulting precipitates were collected by centrifugation and washed with Et2O to give a colorless amorph solid of4 as its hydrochloride (25mg, 100%): [a]£6 +31°{c0.7, H2O); IR (KBr) 3500, 3400, 2990, 2925, 2890 (sh), 2870, 1735, 1730, 1530, 1460, 1430, 1410, 1315, 1290, 1230, 1170, 1110, 1050, 1020cm " To a soln of6 (109mg) in DMF(2ml) were added triethylamine (0.2 ml), 7V,iV' -di-(ter/-butoxycarbonyl)-thiourea (199mg) and mercury (II) chloride (196mg) at 0°C, and the mixture was stirred at 0°C for 2 hours. After addition a large amount of EtOAc, the resulting precipitates were removed by centrifugation. The precipitates were washed with EtOAc. The supernatant and washings were combined, and the soln was washed with water and a satd aq NaCl soln, dried over MgSO4, and filtered. Evaporation of the solvent gave a solid, which was subjected on column chromatography of silica gel. Elution with a mixture ofCHC13 and MeOH (100 : To a soln of 10 in dichloromethane (0.6ml) was added trifluoroacetic acid (0.6 ml), and the mixture was stirred at room temperature for 8 hours. Evaporation of the solvent gave a solid, which was subjected to column chromatography on Diaion HP20 resin. Elution with water gave an oil, which was solidified by removal of water by azeotropic evaporation with MeOH.The solid was dissolved in a small amount of MeOH(50/n\), and to the soln were added a soln of4m hydrogen in dioxane (l ml) and Et2O (5ml) 185, 152, 110, 93, 75, 60and 57. 
